QT - Dispersion

Kardiologiya

Volumn 38, Issue 5, 1998, Pages 58-63

  Nikitin, Yu P ^a   Kuznetsov, A A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0037801694     PISSN: 00229040     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (120)

1. Day C.P., McComb J.M., Campbell R.W.F. QT dispersion: an indication of arrhythmia risk in patients with long QT intervals. Br Heart J 1990;63:342-344.
2. Higham P.D., Campbell R.W.F. QT dispersion. Br Heart J 1994;71:508-510.
3. Statters D.J., Malik M., Ward D.E., Camm A.J. QT dispersion: problems of methodology and clinical significance. J Cardiovasc Electrophysiol 1994;5:672-685.
4. Bayes de Luna., Vinolas X. QT dispersion and heart rate variability. Eur Heart J 1996;17:165-166.
5. Hill J.A., Friedman P.L. Measurement of QT interval and QT dispersion. Lancet 1997;394:894.
6. Han J., Moe G.K. Nonuniform recovery of excitability in ventricular muscle. Circulation 1964;14:44-60.
7. Abildskov J.A., Burgess M.J., Urie P.M. et al. The unidentified content of the ECG. Circ Res 1977;40:3-7.
8. Kuo C.S., Munakata K., Ready C.P., Surawicz B. Characteristics and possible mechanism of ventricular arrhythmia dependent on the dispersion of action potential durations. Circulation 1983;67:1356-1367.
9. Bonatti V., Rolli A., Botti G. Recording of monophasic action potentials of the right ventricle in long QT syndromes complicated by severe ventricular arrhythmias. Eur Heart J 1983;4:168 -179.
10. Janse M.J., Wit A.L. Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischaemia and infarction. Physiol Rev 1989;69:1049-1169.
11. Pogwizd S.M., Corr P.B. Mechanisms underlying the development of ventricular fibrillation during early myocardial ischaemia. Circ Res 1990;66:672-695.
12. Lepeshkin E., Surawicz B. The measurement of the QT interval of the electrocardiogram. Circulation 1952;6:378-388.
13. Sylvein J.C., Horacek B.M., Spencer C.A. et al. QT interval variability on body surface. J Electrocardiol 1984;17:179-188.
14. Mirvis D.M. Spatial variation of QT intervals in normal persons and patients with acute myocardial infarction. J Am Coll Cardiol 1985;5:625-631.
15. De Ambroggi L., Bertoni T., Locati E. et al. Mapping of body surface potentials in patients with the idiopathic long QT syndrome. Circulation 1986;74:1334-1345.
16. Cowan J.C., Yusoff K., Moore M. et al. Importanse of lead selection in QT interval measurement. Am J Cardiol 1988;61:83-87.
17. Abildskov J.A., Vincent G.M., Evans K., Burgess M.J. Distribution of body surface ECG potentials in familial QT interval prolongation. Am J Cardiol 1981;47:480.
18. Mirvis D.M. Body surface distributions of repolarisation forces during acute myocardial infarction. Circulation 1980;62:878-887.
19. Linker N.J., Colonna P., Kekwick C.A. et al. Assessment of QT dispersion in symptomatic patients with congenital long QT syndromes. Am J Cardiol 1992;69:634-638.
20. De Ambroggi L., Taccardi B., Macchi E. Body surface maps of heart potentials: tentative localization of pre-exited areas in forty-two WPW patients. Circulation 1976;54:251-263.
21. Mirvis D.M. Differential electrocardiographic effects of myocardial ischaemia induced by atrial pacing in dogs with various locations of coronary stenosis. Circulation 1983;68:1116-1126.
22. McLaughlin V.W., Flowers N.C., Horan L.G., Killam H.A.W. Surface potential contribution from discrete elements of ventricular wall. Am J Cardiol 1981;34:302-308.
23. Spach M.S., Barr R.C. Ventricular intramural and epicardial potential distributions during ventricular activation and repolarization in dog. Circ Res 1975;37:243-257.
24. Burgess M.J., Green L.S., Millar K. et al. The sequence of normal ventricular recovery. Am Heart J 1972;84:660-669.
25. Abildskov J.A. The sequence of normal recovery of excitability in the dog heart. Circulation 1975;52:442-446.
26. Toyoshima H., Lux R.L., Wyatt R.F. et al. Sequences of early and late phases of repolarization of dog ventricular epicardium. J Electrocardiol 1981;14:143-152.
27. Wilson F.N., Johnston F.D., Cotrim N., Rosenbaum F.F. Relations between the potential variations of the ventricular surfaces and the form of the ventricular ECG in leads from the precordium and the extremities. Trans Assn Am Phys 1941;56:258-271.
28. Franz M.R., Bargheer K., Rafflenbeul W. et al. Monophasic action potential mapping in human subjects with normal ECGs: direct evidence for the genesis of the T wave. Circulation 1987;75:379-386.
29. Cowan J.C., Hilton C.J., Griffiths C.J. et al. Sequence of epicardial repolarization and configuration of the T wave. Br Heart J 1988;60:424-433.
30. Day C.P. Interlead QT variability as measure of temporal dispersion of ventricular recovery. Br Heart J 1990;64:81-82.
31. Higham P.D., Hilton C.J., Aitcheson D.A. et al. QT dispersion does reflect regional variation in ventricular recovery. Circulation 1992;86: Suppl:1319.
32. Higham P.D., Hilton C.J., Aitcheson J.D. et al. QT dispersion: A measure of underlying dispersion of ventricular recovery? Eur Heart J 1993;14:Suppl:86.
33. Zabel M., Portnoy S., Franz M.R. Electrocardiographic indexes of dispersion of ventricular repolarization: an isolated heart validation study. J Am Coll Cardiol 1995;25:746-752.
34. Shimizu W. Concept of activation recovery interval and clinical usefulness of body surface recovery time and recovery time isochrone map. Nippon Rinsho 1995;53:74-81.
35. Zareba W., Badilini F., Moss A.J. Automatic detection of spatial and dynamic heterogenety of repolarisation. J Electrocardiol 1994;27:Suppl:66-71.
36. Katsuki T., Takata S., Usuda K., Kobayashi K. QRST isointegral maps on exercise in patients with congenital long QT syndrome.Nippon Rinsho 1995;53:145-150.
37. Schwartz P.J., Moss A.J., Crampton R.S. Long QT syndrome international prospective study. PACE 1987;10:1032-1035.
38. Moss A.J. Prolonged QT interval syndromes. JAMA 1986;256:2985 -2987.
39. Towbin J.A. New revelation about the long-QT syndrome. N Engl J Med 1995;333:384-385.
40. Attali B. A new wave for heart rhythms. Nature 1996;384:24-25.
41. Sedgwick M.L., Rasmussen H.S., Cobbe S.M. Effects of the class III antiarrhythmic drug dofetilide on ventricular monophasic action potential duration and QT dispersion in stable angina pectoris. Am J Cardiol 1992;70:1432-1437.
42. Higham P.D., Furniss S.S., Campbell R.W.F. QT dispersion and components of the QT interval in ischaemia and infarction. Br Heart J 1995;73:32-36.
43. Day C.P., McComb J.M., Matthews J., Campbell R.W.F. Reduction in QT dispersion by sotalol following myocardial infarction. Eur Heart J 1991;12:423-427.
44. Glancy J.M., Garratt C.J., Woods K.L., de Bono D.P. QT dispersion and mortality after myocardial infarction. Lancet 1995;345:1553 -1558.
45. Potratz J., Djonlagic H., Mentzel H. et al. Prognostic significance of the QT-dispersion in patients with acute myocardial infarction. Eur Heart J 1993;14:Suppl:254.
46. Glancy J.M., Garratt C.J., Woods K.L., de Bono D.P. Use of lead adjustment formulas for QT dispersion after myocardial infarction. Br Heart J 1995;74:676-679.
47. Fang Q., Doig J.C., Gumbrielle T.P.M. et al. Spatial correlation of infarct site and QTc. Br Heart J 1995;73:Suppl 3:21.
48. Doi Y., Takada K., Mihara H. et al. QT dispersion in acute myocardial infarction with special reference to left ventriculographic findings. Jpn Heart J 1995;36:73-81.
49. Lee H.S., Cross S.G., Rawles J. et al. QTc dispersion in patients with coronary artery disease - effect of exercise, dobutamine, dipyridamole myocardial stress. Eur Heart J 1993;14:Suppl:210.
50. Perkiomaki J., Koistinen J., Linnaluoto M. Dispersion of QT-interval at rest and during exercise in healthy subjects and patients with coronary artery disease. Eur Heart J 1993;14:Suppl:254.
51. Aggelakas S., Dritsas A., Michailidis A. et al. Exercise induced ventricular arrhythmia is associated with increased QT dispersion. Br Heart J 1995;73:Suppl 3:20.
52. Stevenson R., Higham P.G., Campbell R.W.F., Furniss S.S. QT dispersion and acute coronary oclusion in man. Eur Heart J 1993;14:Suppl:461.
53. Higham P.D., Reid D.S., Campbell R.W.F. et al. Reperfusion, acute myocardial infarction and QT dispersion. Eur Heart J 1992;13:Suppl:448.
54. Moreno F.L., Willanneva T., Karagonnis L.A. et al. Reduction in QT interval dispersion by succesful thrombolitic therapy in acute myocardial infarction. TEAM study investigators. Circulation 1994;90:94-100.
55. Davidson N.C., Darbar D., Luck J. et al. QT interval dispersion predicts cardiac death in patients with peripheral vascular disease. Br Heart J 1995;73:Suppl 3:20.
56. Doroghazi R.M., Childers R. Time-related changes in the Q-T interval in acute myocardial infarction: possible relation to local hypocalcemia. Am J Cardiol 1978;41:684-688.
57. Boineau J.P., Cox J.L. Slow ventricular activation in acute myocardial infarction: a source of re-entrant premature ventricular contraction. Circulation 1973;48:702-713.
58. Buja G., Miorelli M., Turrini P. et al. Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmia and sudden death. Am J Cardiol 1993;72:973-976.
59. Dritsas A., Puri S., Davis G. et al. QT dispersion is increased in hypertrophic cardiomiopthy compared with secondary left ventricular hypertrophy. Eur Heart J 1993;14:Suppl:212.
60. Dritsas A., Sbarauni E., Gilligan D. et al. QT-interval abnormalities in hypertrophic cardiomyopathy. Clin Cardiol 1992;15:739-742.
61. Sousa M.J., Aranha J., Cotrim C. et al. The QTc interval and its dispersion in hypertrophic myocardiopathy: its relation to complex ventricular arrhythmias and the effect of anti-arrhythmia agents. Rev Port Cardiol 1995;14:461-467.
62. Chang A.C., McAreavey D., Fananapazir L. Identification of patients with hypertrophic cardiomyopathy at high risk for sudden death. Curr Opin Cardiol 1995;10:9-15.
63. Clarkson P.B., Naas A.A., McMahon A. et al. QT dispersion in essential hypertension. QJM 1995;88:327-332.
64. Mayet J., Shahi M., McGrath K. et al. Regression of left ventricular hypertrophy is accompaned by a reduction in QT dispersion. Br Heart J 1995;73:Suppl 3:21.
65. Cooklin M., O'Gorman D.J., Sheridan D.J. Increased QT dispersion in patients with electrocardiographic evidence of left ventricular hypertrophy. Eur Heart J 1993;14:Suppl:212.
66. Barr C.S., Naas A., Freeman M. et al. QT dispersion and sudden unexpected death in chronic heart failure. Lancet 1994;343:327-329.
67. Barr C.S. Enalapril reduced QT dispersion in patients with mild, asymptomatic ventricular dysfunction. Br Heart J 1995;73:Suppl 3:27.
68. Struthers A.D. Two new culprits in cardiovascular disease: QT dispersion and aldosterone. J Hum Hypertens 1995;9:659-661.
69. Fei L., Goldman J.H., Prasad K. et al. QT dispersion and RR variations on 12-lead ECGs in patients with congestive heart failure secondary to idiopathic dilated cardiomyopathy. Eur Heart J 1996;17:258-263.
70. Tieleman R.G., Crijns H.J.G.M., Wiesfeld A.C.P. et al. Increased dispersion of refractoriness in the absence of QT prolongation in patients with mitral valve prolapse and ventricular arrhythmias. Br Heart J 1995;73:37-40.
71. Wei K., Dorian P., Newman D., Langer A. Association between QT dispersion and autonomic dysfunction in patients with diabetes mellitus. J Am Coll Cardiol 1995;26:859-863.
72. Sarubbi B., Ducceschi V., Esposito V. et al. Assessment of dispersion of ventricular recovery in patients with chronic obstructive pulmonary disease. Cardiologia 1995;40:247-251.
73. Kiely D.G., Cargill R.I., Grove A. et al. Abnormal myocardial repolarisation in response to hypoxaemia and fenoterol. Thorax 1995;50:1062-1066.
74. Kiely D.G., Cargill R.I., Lipworth B.J. Effects of hypercapnia on hemodynamic, inotropic, lusitropic, and electrophysiologic indices in humans. Chest 1996; 109:1215-1221.
75. Inoue H., Toda I., Nozaki A. et al. Effects of bretylium tosylate on inhomogeneity of refractoriness and ventricular fibrillation threshold in canine hearts with quinidine-induced long QT interval. Cardiovasc Res 1985;19:655-660.
76. Roden D.M., Woosley A.L. QT prolongation and arrhythmia supression. Am Heart J 1985;109:411-415.
77. Hii J.T., Wyse D.G., Gillis A.M. et al. Precordial QT interval dispersion as marker of torsade de pointes: Disparate effects of class la antiarrhythmic drugs and amiodarone. Circulation 1992;86:1376 -1382.
78. Nowinski K., Bergfeldt L. "Normal" response of the QT interval and QT dispersion following intravenous injection of the sodium channel blocker disopyramide: methodological aspects. Cardiovasc Drugs Ther 1995;9:573-801.
79. Hohnloser S.H., Singh B.N. Proarrhythmia with class III antiarrhythmic drugs: definition, electrophysiologic mechanisms, incidence, predisposing factors, and clinical implications. J Cardiovasc Electrophysiol 1995;6:920-936.
80. Darpe B., Vallin H., Almgren O. et al. Selective 1k blocker almokalant exhibits class IIIspecific effects on the repolarization and refractoriness of the human heart: a study of healthy volunteers using right ventricular monophasic action potential recordings. J Cardiovasc Pharmacol 1995;26:530-540.
81. Higham P.D., Thomas S.L., Ford G.A. et al. Increased QT dispersion as a marker for arrhythmogenesis: lesson from terodeline. Eur Heart J 1993;14:Suppl:39.
82. Thomas S.H., Higham P.D., Hartigan Go. K. et al. Concentration dependent cardiotoxicity of terodiline in patients treated for urinary incontinence. Br Heart J 1995;74:53-56.
83. Surawicz B., Knoebel S. Long QT: good, bad or indiferent? J Am Coll Cardiol 1984;4:398-413.
84. O'Donnel J., Knoebel S.B., Lovelace D.E., McHenry P.L. Computer quantification of Q-T interval and terminal T wave (aT-eT) intervals during exercise: methodology and results in normal men. Am J Cardiol 1981;47:1168-1172.
85. O'Donnel J., Lovelace D.E., Knoebel S.B., McHenry P.L. Behavior of the terminal T-wave during exercise in normal subjects, patients with symptomatic coronary artery disease and apparently healthy subjects with abnormal ST segment depression. J Am Coll Cardiol 1985;5:78-84.
86. Ahnve S. Errors in the visual determination of corrected QT(QTc) interval during acute myocardial infarction. J Am Coll Cardiol 1985;5:699-702.
87. Ahnve S. Correction of the QT interval for heart rate: review of different formulas and the use of Bazett's formula in myocardial infarction. Am Heart J 1985;109:568-574.
88. Moss A.J. Measurement of the QT interval and the risk associated with QTc interval prolongation: a review. Am J Cardiol 1993;72:23B -25B.
89. Fei L., Statters D.J., Camm A.J. QT-interval dispersion on 12 lead ECG in normal subjects. Its reproductibility and relation to the T wave. Am Heart J 1994; 127:1654-1655.
90. Browne K.F., Prystowsky E., Heger J.J. et al. Modulation of the QT interval by the autonomie nervous system. PACE 1983;6:1050-1056.
91. Bexton R.S., Vallin H.O., Camm A.J. Diurnal variations of the QT interval - influence of the autonomie nervous system. Br Heart J 1986;55:253-258.
92. Pellerin D., Maisonblanche P., Leclerq J.F. et al. Variations of the QT interval induced by spontaneous short-term heart rate changes. Eur Heart J 1993;14:Suppl:212.
93. Lombardi F., Sandrone G., Venturati M. et al. Analysis of RR and RT variabilities after myocardial infarction. Eur Heart J 1993;14:Suppl:255.
94. Pai G.R., Rawles J.M. The QT interval in atrial fibrillation. Br Heart J 1989;61:510-513.
95. Vainer J., van der Steld B., Smeets J.L.R.M. et al. Beat-to-beat changes of QT interval in normal heart sinus rhythm and atrial pacing. Eur Heart J 1993;14:Suppl:255.
96. Bazett H.S. An analysis of time relations of electrocardiograms. Heart 1920;7:353-367.
97. Taran L.M., Szilagyi N. The duration of the electrical systole (QT) in acute rheumatic carditis in children. Am Heart J 1947;33:14-26.
98. Fei L., Statters D.J., Anderson M.H. et al. Is there a prolonged QT interval in sudden cardiac death survivors with a "normal" QTc? Am Heart J 1994;128:73-76.
99. Zabel M., Killer B.S., Woosley R.L., Franz M.R. Frequency-dependent changes in the dispersion of repolarization and recovery time: Implications for the measurement of QT dispersion. PACE 1994; 17:762.
100. Fei L., Sadoul N., Malik M., Camm A.J. QT dispersion on simultaneous 12-lead electrocardiographic recordings in patients with cardiac arrhythmias: beat-to-beat variations and cycle length dependence. PACE 1995;18;655.
101. Priori S.G., Napolitano C., Diehl L., Schwartz P.J. Dispersion of the QT interval - a marker of therapeutic efficacy in the idiopathic long QT syndrome. Circulation 1994;89:1681-1689.
102. Hnatkova K., Malik M., Kautzner J. et al. Adjustment of QT dispersion assessed from 12 lead ECGs for different numbers of analysed electrocardiographic leads:comparison of stability of different methods. Br Heart J 1994;72:390-396.
103. Glancy J.M., Garratt C.J., Woods K.L., De Bono D.P. Three-lead measurement of QTc dispersion. J Cardiovasc Electrophysiol 1995;6:987-992.
104. Zareba W., Moss A.J., le Cessie S. Dispersion of ventricular repolarization and sudden cardiac death in ischaemic heart disease. Am J Cardiol 1994;74:550-553.
105. Murray A., McLaughlin N.B., Burke J.P. et al. Errors in manual measurement of QT intervals. Br Heart J 1994;71:386-390.
106. McLaughlin N.B., Campbell R.W.F., Murray A. Comparison of automatic QT measurement techniques in the normal 12 lead ECG. Br Heart J 1995;74:84-89.
107. Kautzner J., Gang Y., Camm J., Malic M. Short- and long-term reproducability of QT, QTc and QT dispersion measurement in healthy subjects. PACE 1994;17:928-937.
108. Stoletniy L.N., Pai R.G. Usfulness of QTc dispersion in interpreting exercise electrocardiograms. Am Heart J 1995;130:918 -921.
109. Gill J.S., Anttonen O., Ward D.E., Camm A.J. Increased QT dispersion in patients with idiopathic ventricular tachycardia associated with syncope. Eur Heart J 1993; 14:Suppl:254.
110. Shimizu W., Ohe T., Kurita T. et al. Effects of verapamil and propranolol on early after depolarizations and ventricular arrhythmias induced by epinephrine in congenital long QT syndrome. J Am Coll Cardiol 1995;26:1299-1309.
111. Bogun F. QT dispersion in nonsustained ventricular tachycardia and coronary artery disease. Am J Cardiol 1996;77:256-259.
112. Perkiomaki J., Koistinen J., Huikuri H. Dispersion of QT interval in patients with and without susceptibility to ventricular tachyarrhythmias after previous myocardial infarction. J Am Coll Cardiol 1995;26:174-179.
113. Böhringer K., Kühlkamp V., Seipel L. Early after depolarization in polymorphic ventricular tachycardia without QT prolongation. Z Kardiol 1995;84:394-399.
114. Hohnloser S.H., van de Loo A., Baedeker F. Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine. J Am Coll Cardiol 1995;26:852-858.
115. Pye M., Quinn A.C., Cobbe S.M. QT interval dispersion: a non-invasive marker of susceptibility to arrhythmia in patients with sustained ventricular arrhythmias? Br Heart J 1993;71:511-514.
116. Davey P.P., Bateman J., Malligan I.P. et al. QT interval dispersion in chronic heart failure and left ventricular hypertrophy: relation to autonomic nervous system and Holter tape abnormalities. Br Heart J 1994;71:268-273.
117. Goldner B., Brandspiegel H.Z., Horwitz L. et al. Utility of QT dispersion combined with the signal-averaged electrocardiogram in detecting patients susceptible to ventricular tachyarrhythmia. Am J Cardiol 1995;76:1192-1194.
118. Leitch J., Basta M., Dobson A. QT dispersion does not predict early ventricular fibrillation after acute myocardial infarction. Pacing Clin Electrophysiol 1995;18:45-48.
119. Cui G., Sen L., Sager P. et al. Effects of amiodarone, sematilide, and sotalol on QT dispersion. Am J Cardiol 1994;74:896-900.
120. Statters D.J., Panagos A., Fei L. et al. How does beta-blockade protect patients with congenital long QT syndromes? Br Heart J 1995;73:Suppl 3:21.